Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.
Martini P, Boschi A, Cicoria G, Zagni F, Corazza A, Uccelli L, Pasquali M, Pupillo G, Marengo M, Loriggiola M, Skliarova H, Mou L, Cisternino S, Carturan S, Melendez-Alafort L, Uzunov NM, Bello M, Alvarez CR, Esposito J, Duatti A. Martini P, et al. Appl Radiat Isot. 2018 Sep;139:325-331. doi: 10.1016/j.apradiso.2018.05.033. Epub 2018 May 30. Appl Radiat Isot. 2018. PMID: 29936404
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct 100Mo(p,2n) reaction.
Uzunov NM, Melendez-Alafort L, Bello M, Cicoria G, Zagni F, De Nardo L, Selva A, Mou L, Rossi-Alvarez C, Pupillo G, Di Domenico G, Uccelli L, Boschi A, Groppi F, Salvini A, Taibi A, Duatti A, Martini P, Pasquali M, Loriggiola M, Marengo M, Strada L, Manenti S, Rosato A, Esposito J. Uzunov NM, et al. Phys Med Biol. 2018 Sep 19;63(18):185021. doi: 10.1088/1361-6560/aadc88. Phys Med Biol. 2018. PMID: 30229740 Free article.
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V.
Mou L, De Dominicis L, Cisternino S, Skliarova H, Campostrini M, Rigato V, De Nardo L, Meléndez-Alafort L, Esposito J, Haddad F, Pupillo G. Mou L, et al. Among authors: melendez alafort l. Pharmaceuticals (Basel). 2023 Dec 23;17(1):26. doi: 10.3390/ph17010026. Pharmaceuticals (Basel). 2023. PMID: 38256860 Free PMC article.
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery.
Jalilian AR, Ocampo-García B, Pasanphan W, Sakr TM, Melendez-Alafort L, Grasselli M, Lugao AB, Yousefnia H, Dispenza C, Janib SM, Khan IU, Maurin M, Ulański P, Loo SCJ, Safrany A, Osso JA Jr, Duatti A, Katti KV. Jalilian AR, et al. Among authors: melendez alafort l. Pharmaceutics. 2022 May 15;14(5):1060. doi: 10.3390/pharmaceutics14051060. Pharmaceutics. 2022. PMID: 35631646 Free PMC article. Review.
Labelling of Re-ABP with 188Re for bone pain palliation.
Arteaga de Murphy C, Ferro-Flores G, Pedraza-López M, Meléndez-Alafort L, Croft BY, Ramírez FM, Padilla J. Arteaga de Murphy C, et al. Appl Radiat Isot. 2001 Mar;54(3):435-42. doi: 10.1016/s0969-8043(00)00296-7. Appl Radiat Isot. 2001. PMID: 11214878
54 results